Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 40

Results: 10

Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5105, doi. 10.1038/onc.2014.458

By:

Fulda, S;
Kögel, D

Publication type:

Article

TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5163, doi. 10.1038/onc.2014.437

By:

Lozupone, F;
Borghi, M;
Marzoli, F;
Azzarito, T;
Matarrese, P;
Iessi, E;
Venturi, G;
Meschini, S;
Canitano, A;
Bona, R;
Cara, A;
Fais, S

Publication type:

Article

KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5141, doi. 10.1038/onc.2014.435

By:

Chen, H Y;
Hu, J Y;
Chen, T H;
Lin, Y C;
Liu, X;
Lin, M Y;
Lang, Y D;
Yen, Y;
Chen, R H

Publication type:

Article

Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5114, doi. 10.1038/onc.2014.434

By:

Chen, J;
Lan, T;
Zhang, W;
Dong, L;
Kang, N;
Zhang, S;
Fu, M;
Liu, B;
Liu, K;
Zhang, C;
Hou, J;
Zhan, Q

Publication type:

Article

MUC1-C activates the TAK1 inflammatory pathway in colon cancer.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5187, doi. 10.1038/onc.2014.442

By:

Takahashi, H;
Jin, C;
Rajabi, H;
Pitroda, S;
Alam, M;
Ahmad, R;
Raina, D;
Hasegawa, M;
Suzuki, Y;
Tagde, A;
Bronson, R T;
Weichselbaum, R;
Kufe, D

Publication type:

Article

Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5175, doi. 10.1038/onc.2014.441

By:

Visciano, C;
Liotti, F;
Prevete, N;
Cali', G;
Franco, R;
Collina, F;
de Paulis, A;
Marone, G;
Santoro, M;
Melillo, R M

Publication type:

Article

SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5128, doi. 10.1038/onc.2014.439

By:

Lewis, C A;
Brault, C;
Peck, B;
Bensaad, K;
Griffiths, B;
Mitter, R;
Chakravarty, P;
East, P;
Dankworth, B;
Alibhai, D;
Harris, A L;
Schulze, A

Publication type:

Article

A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5198, doi. 10.1038/onc.2014.443

By:

Wang, N;
Ding, H;
Liu, C;
Li, X;
Wei, L;
Yu, J;
Liu, M;
Ying, M;
Gao, W;
Jiang, H;
Wang, Y

Publication type:

Article

p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5152, doi. 10.1038/onc.2014.436

By:

Long, J S;
Schoonen, P M;
Graczyk, D;
O'Prey, J;
Ryan, K M

Publication type:

Article

The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.

Published in:

Oncogene, 2015, v. 34, n. 40, p. 5206, doi. 10.1038/onc.2015.314

By:

Guan, D;
Factor, D;
Liu, Yu;
Wang, Z;
Kao, H-Y

Publication type:

Article